Haleon has entered a five-year partnership with Microsoft to expand its use of digital technology, data and artificial intelligence across its consumer health operations.
The London-based company manufactures Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins.
The company sells products in 170 markets across six health categories. According to Haleon, its brands reach 1.4 billion consumers worldwide.
The agreement builds on Haleon’s current deployment of Microsoft 365 Copilot. The collaboration could enable employees to automate administrative tasks and redirect time to other priorities.
The two companies plan to develop AI applications for consumer insights, product innovation, supply chain management and commercial operations. The arrangement extends Haleon’s existing use of Microsoft’s cloud infrastructure.
Claire Dickson, Chief Digital and Technology Officer at Haleon, says the partnership advances how the company applies technology to its business model.
“This collaboration marks a major step forward in how we use digital, data and AI to deliver our global strategy – driving growth, improving productivity and building a more agile, performance-focused culture,” she says.
Haleon plans to use the technology to accelerate scientific research and clinical content development. The company intends to produce health information for consumers more quickly through these tools.
The AI systems could also support marketing operations through personalised content creation. According to Haleon, the technology will inform decisions across the organisation using data analysis.
Claire adds that the combination of Microsoft’s infrastructure and Haleon’s consumer health expertise could accelerate implementation.
“By combining Microsoft’s cloud and AI capabilities with Haleon’s deep consumer health expertise, we’re accelerating our AI progress – simplifying how we work, unlocking more value from our data, accelerating innovation and helping our teams make faster, smarter decisions to benefit our consumers,” she says.
Haleon uses Microsoft Azure as its primary cloud platform. The company has integrated Microsoft Copilot into daily workflows across departments.
The infrastructure provides data analytics capacity and enterprise security features. Haleon has implemented identity protection and governance protocols to manage AI operations.
The security framework allows Haleon to control access to data whilst scaling AI deployment. The architecture supports the company’s compliance requirements across international markets.
Darren Hardman, CEO of Microsoft UK and Ireland, says Haleon is implementing AI at speed.
“Haleon is moving with real pace and purpose on its AI journey, using Microsoft cloud and AI capabilities to turn ambition into impact across the entire organisation,” he says.
According to Darren, Microsoft will support Haleon’s expansion of AI capabilities.
“We’re proud to support Haleon as it scales AI securely and responsibly, helping the company unlock more value from its data and accelerate its mission to deliver better everyday health to millions more people around the world,” he says.
CDTO
CEO, Microsoft UK & Ireland
Healthcare Magazine connects the leading Healthcare executives of the world's largest brands. Our platform serves as a digital hub for connecting industry leaders, covering a wide range of services including media and advertising, events, research reports, demand generation, information, and data services. With our comprehensive approach, we strive to provide timely and valuable insights into best practices, fostering innovation and collaboration within the Healthcare community. Join us today to shape the future for generations to come.
Leave a Reply